General Information
Revision date
2011-11-30
Product name
BuscopanTM Injectable Solution
Chemical name
Antispasmodic
CAS No.
Mixture
1.2.1 Relevant identified uses
For the control abdominal pain associated with spasmodic colic, flatulent colic, and simple impactions in horses 2
Manufacturer Name
Transportation Emergency: For Chemical
Icons in SDS
Company Information
company name
Boehringer Ingelheim Vetmedica, Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
OSHA Regulatory Status Emergency Overview Physical State: Liquid solution packaged in 50 mL bottle. Color: Colorless Odor: Odorless WARNING! May be harmful if swallowed. Allergic reactions can occur. For use in horses only. Not for human use.
Precautionary statements
Keep only in original container. Keep at a temperature between 2 - 7°C. Do not freeze. Accidental human injection can cause serious local reactions or anaphylactic reaction and systemic effects. Avoid contact with eyes, skin and clothing. Wash thoroughly with soap and water after handling. Wear suitable gloves and eye/face protection. Spills: Cover with absorbent or contain. Collect and incinerate. If swallowed, seek medical advice immediately and show this container or label. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Have the product container or label with you when calling a poison control center or doctor, or going for treatment. Keep out of reach of children. Keep away from food, drink, and animal feedstuffs.
Potential health effects
Inhalation: Not expected to be an inhalation hazard with prescribed use. Eye Contact: Not expected to be a hazard to the eye with prescribed use. Exposure to liquid in eye may cause mild transient eye irritation. Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions. May cause skin sensitization by contact. Ingestion: Not expected to be an ingestion hazard with prescribed use. May be harmful if swallowed. Ingestion may cause nausea and systemic effects. Injection: Swelling at injection site may occur
Potential chronic health
Possible hypersensitization (development of abnormal sensitivity) Target Organ(s): Skin OSHA Regulatory Status: Hazardous (Exempt)
Environmental hazards
No data available